Cardio Diagnostics Holdings, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities
Cardio Diagnostics Holdings, Inc. (CDIO) reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $6.88 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-06-30 was $3.44K, a 26.65% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2026-03-31 was $3.44K, a 26.69% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-12-31 was $2.29K, a 26.70% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for the quarter ending 2025-09-30 was $3.13K, a 19.36% decline year-over-year.
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2025 was $14.80K, a 20.60% decline from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2024 was $18.64K, a 38.87% decline from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2023 was $30.49K, a 423.09% increase from fiscal 2022.
- Cardio Diagnostics Holdings, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2022 was $5.83K.
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 3 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 6 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 9 month | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $6.88K 10-Q · filed 2026-08-07 | $9.17K derived: sum of 3 quarters · filed 2026-08-07 | $12.30K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.44K 10-Q · filed 2026-05-15 | $5.73K derived: sum of 2 quarters · filed 2026-05-15 | $8.86K derived: sum of 3 quarters · filed 2026-05-15 | $13.55K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $2.29K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $5.42K derived: sum of 2 quarters · filed 2026-03-13 | $10.11K derived: sum of 3 quarters · filed 2026-08-07 | $14.80K 10-K · filed 2026-03-13 |
| 2025-09-30 | $3.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $7.82K derived: sum of 2 quarters · filed 2026-08-07 | $12.51K 10-Q · filed 2025-11-12 | $15.64K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $4.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $9.38K 10-Q · filed 2026-08-07 | $12.51K derived: sum of 3 quarters · filed 2026-08-07 | $16.39K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $4.69K 10-Q · filed 2026-05-15 | $7.82K derived: sum of 2 quarters · filed 2026-05-15 | $11.70K derived: sum of 3 quarters · filed 2026-05-15 | $17.51K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $3.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $7.01K derived: sum of 2 quarters · filed 2026-03-13 | $12.82K derived: sum of 3 quarters · filed 2026-03-13 | $18.64K 10-K · filed 2026-03-13 |
| 2024-09-30 | $3.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $9.70K derived: sum of 2 quarters · filed 2025-11-12 | $15.51K 10-Q · filed 2025-11-12 | $19.39K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $5.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $11.63K 10-Q · filed 2025-08-14 | $15.51K derived: sum of 3 quarters · filed 2025-08-14 | $24.38K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $5.82K 10-Q · filed 2025-05-15 | $9.70K derived: sum of 2 quarters · filed 2025-05-15 | $18.57K derived: sum of 3 quarters · filed 2025-05-15 | $27.44K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $3.88K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $12.75K derived: sum of 2 quarters · filed 2025-03-20 | $21.62K derived: sum of 3 quarters · filed 2025-03-20 | $30.49K 10-K · filed 2025-03-20 |
| 2023-09-30 | $8.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $17.74K derived: sum of 2 quarters · filed 2024-11-13 | $26.61K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $8.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $17.74K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $8.87K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $5.83K 10-K · filed 2024-04-01 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |